A pilot case-control study of gamma-radiation sensitivity and risk of papillary thyroid cancer

Thyroid. 2005 Feb;15(2):94-9. doi: 10.1089/thy.2005.15.94.

Abstract

In vitro gamma-radiation-induced chromatid breaks per cell (b/c) in lymphocytes may be associated with risk of papillary thyroid cancer (PTC). This pilot case-control study involved 106 patients with thyroid disease (57 with PTC and 49 with benign thyroid disease) and 105 cancer-free matched controls. Multivariate logistic regression analyses identified that an elevated gamma-radiation-induced b/c value was a risk factor for PTC (adjusted odds ratio = 4.54; 95% CI, 2.07-9.95), and a dose-response relationship was evident when the b/c values were categorized into tertiles. High levels of chromatid breaks induced by gamma-radiation may constitute an independent risk factor for PTC, but further study is needed.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Papillary / epidemiology*
  • Case-Control Studies
  • Female
  • Gamma Rays / adverse effects*
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neoplasms, Radiation-Induced / epidemiology*
  • Pilot Projects
  • Risk Factors
  • Thyroid Diseases / epidemiology
  • Thyroid Neoplasms / epidemiology*